Ligand Pharmaceuticals LGND Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's deferred tax assets and other non-current assets?
- Ligand Pharmaceuticals (LGND) reported deferred tax assets and other non-current assets of $12.99M in Q1 2026.
- How has Ligand Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?
- Ligand Pharmaceuticals's deferred tax assets and other non-current assets increased by 64.6% year-over-year, from $7.89M to $12.99M.
- What is the long-term trend for Ligand Pharmaceuticals's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's deferred tax assets and other non-current assets has grown at a 24.1% compound annual growth rate (CAGR), from $4.27M to $12.58M.